Enfusion, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
ENFN
Enfusion, INCDEFA14A: Enfusion and Clearwater Analytics Update Merger Agreement: Joint Election Procedure Modified
Enfusion, Inc. and Clearwater Analytics Holdings, Inc. announce a supplement to their merger agreement, modifying the joint election procedure for Enfusion stockholders.
ENFN
Enfusion, INCClearwater Analytics is set to acquire Enfusion, a provider of SaaS solutions for investment management, in a transaction valued at approximately $1.5 billion.
ENFN
Enfusion, INCEnfusion and Clearwater Analytics announced the expiration of the Hart-Scott-Rodino Act waiting period, moving their proposed acquisition closer to completion, expected in the second quarter of 2025.
ENFN
Enfusion, INCDEFA14A: Enfusion and Clearwater Analytics Announce Merger: Aims to Revolutionize Investment Technology
Enfusion and Clearwater Analytics are set to merge, creating a comprehensive front-to-back technology platform for the investment industry, with the deal expected to close in the second quarter of 2025.
ENFN
Enfusion, INCEnfusion has entered into a definitive agreement to be acquired by Clearwater Analytics, with the transaction expected to close in Q2 2025, aiming to create a comprehensive front-to-back platform for investment management.
ENFN
Enfusion, INCEnfusion, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, with key proposals including the election of directors and ratification of the company's accounting firm.
ENFN
Enfusion, INCEnfusion, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to vote on the election of directors and ratification of the company's independent auditor.